{"id":"https://openalex.org/W2184486465","doi":null,"title":"Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro.","display_name":"Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro.","publication_year":2009,"publication_date":"2009-10-01","ids":{"openalex":"https://openalex.org/W2184486465","mag":"2184486465","pmid":"https://pubmed.ncbi.nlm.nih.gov/19946348"},"language":"en","primary_location":{"id":"pmid:19946348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19946348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iranian biomedical journal","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042403833","display_name":"Fatemeh Hajighasemi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119025939","display_name":"Shahed University","ror":"https://ror.org/01e8ff003","country_code":"IR","type":"education","lineage":["https://openalex.org/I119025939"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Fatemeh Hajighasemi","raw_affiliation_strings":["Dept. of Immunology, Faculty of Medicine, Shahed University, Tehran, Iran","Department of Immunology, Faculty of Medicine, Shahed University, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Immunology, Faculty of Medicine, Shahed University, Tehran, Iran","institution_ids":["https://openalex.org/I119025939"]},{"raw_affiliation_string":"Department of Immunology, Faculty of Medicine, Shahed University, Tehran, Iran","institution_ids":["https://openalex.org/I119025939"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027170138","display_name":"Sakineh Hajighasemi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119025939","display_name":"Shahed University","ror":"https://ror.org/01e8ff003","country_code":"IR","type":"education","lineage":["https://openalex.org/I119025939"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Sakineh Hajighasemi","raw_affiliation_strings":["Mostafa Khomeini Hospital, Shahed University, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mostafa Khomeini Hospital, Shahed University, Tehran, Iran","institution_ids":["https://openalex.org/I119025939"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I119025939"],"apc_list":null,"apc_paid":null,"fwci":1.2001,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.75154562,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"13","issue":"4","first_page":"223","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":1.0},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7900000214576721},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9559999704360962},{"id":"https://openalex.org/keywords/mmp-2","display_name":"MMP-2","score":0.9929999709129333},{"id":"https://openalex.org/keywords/leukemia-cell-lines","display_name":"leukemia cell lines","score":0.7929999828338623},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.7210000157356262},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/leukemia-treatment","display_name":"leukemia treatment","score":0.6510000228881836},{"id":"https://openalex.org/keywords/molt-4-cells","display_name":"MOLT-4 cells","score":0.7960000038146973},{"id":"https://openalex.org/keywords/jurkat-cells","display_name":"Jurkat cells","score":1.0},{"id":"https://openalex.org/keywords/u937-cells","display_name":"U937 cells","score":0.9760000109672546},{"id":"https://openalex.org/keywords/phorbol-myristate-acetate","display_name":"phorbol myristate acetate","score":0.9160000085830688},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.921999990940094}],"concepts":[{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.7653300166130066},{"id":"https://openalex.org/C179464577","wikidata":"https://www.wikidata.org/wiki/Q1632589","display_name":"Jurkat cells","level":4,"score":0.6531418561935425},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.643241286277771},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5777820348739624},{"id":"https://openalex.org/C108634530","wikidata":"https://www.wikidata.org/wiki/Q7863610","display_name":"U937 cell","level":3,"score":0.5524571537971497},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.5169317126274109},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4896100163459778},{"id":"https://openalex.org/C109523444","wikidata":"https://www.wikidata.org/wiki/Q424216","display_name":"Matrix metalloproteinase","level":2,"score":0.460041344165802},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42045271396636963},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41294416785240173},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3977629542350769},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3939356803894043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38365620374679565},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33686259388923645},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33656740188598633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3204413652420044},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.18456906080245972},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.17700141668319702},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16155454516410828},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.11896419525146484},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002273","descriptor_name":"Carcinogens","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011433","descriptor_name":"Propranolol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013755","descriptor_name":"Tetradecanoylphorbol Acetate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019169","descriptor_name":"Jurkat Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020298","descriptor_name":"U937 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020778","descriptor_name":"Matrix Metalloproteinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:19946348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19946348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iranian biomedical journal","raw_type":"Comparative Study"},{"id":"mag:2184486465","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19946348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W415886809","https://openalex.org/W1966201937","https://openalex.org/W1966813120","https://openalex.org/W1973199147","https://openalex.org/W1975807709","https://openalex.org/W1980747947","https://openalex.org/W1982031323","https://openalex.org/W1984525830","https://openalex.org/W1991329538","https://openalex.org/W1998045778","https://openalex.org/W2005707246","https://openalex.org/W2010549888","https://openalex.org/W2012041649","https://openalex.org/W2014901791","https://openalex.org/W2018549376","https://openalex.org/W2023572761","https://openalex.org/W2047427057","https://openalex.org/W2057646089","https://openalex.org/W2062738813","https://openalex.org/W2073933577","https://openalex.org/W2084747789","https://openalex.org/W2091582008","https://openalex.org/W2093048926","https://openalex.org/W2096478643","https://openalex.org/W2102018049","https://openalex.org/W2107441731","https://openalex.org/W2111419867","https://openalex.org/W2112043977","https://openalex.org/W2138150045","https://openalex.org/W2144409619","https://openalex.org/W2161832319","https://openalex.org/W2165630642","https://openalex.org/W2171714007","https://openalex.org/W2171998177","https://openalex.org/W2219652465","https://openalex.org/W2228144567","https://openalex.org/W2408006280"],"related_works":["https://openalex.org/W2148747088","https://openalex.org/W2169876742","https://openalex.org/W2150376006","https://openalex.org/W2042546724","https://openalex.org/W2002821992","https://openalex.org/W2060654795","https://openalex.org/W2539836675","https://openalex.org/W2106504686","https://openalex.org/W1982031323","https://openalex.org/W1975045288"],"abstract_inverted_index":{"BACKGROUND:":[0],"Beta-adrenergic":[1],"blocking":[2],"agents":[3],"have":[4,33,229],"been":[5,34],"broadly":[6],"used":[7,104],"for":[8,138],"treatment":[9,233],"of":[10,27,38,64,122,131,143,197,234],"many":[11],"cardiovascular":[12],"diseases":[13],"such":[14,51],"as":[15,52],"arterial":[16],"hypertension":[17],"and":[18,24,55,73,95,97,116,159,162,179,191],"ischemic":[19],"heart":[20],"failure.":[21],"Anti-tumoral,":[22],"anti-inflammatory":[23],"anti-angiogenesis":[25],"effects":[26,63],"propranolol":[28,65,123,218],"(a":[29],"non-selective":[30],"beta-adrenergic":[31],"blocker)":[32],"shown.":[35],"Angiogenesis":[36],"(replenish":[37],"the":[39,62,127,147,198],"pre-existing":[40],"vascular":[41,67],"networks)":[42],"plays":[43],"a":[44,210],"critical":[45],"role":[46],"in":[47,82,87,105,112,126,146,165,183,214,225,232],"some":[48],"pathological":[49],"conditions":[50],"tumor":[53],"expansion":[54],"metastasis.":[56],"In":[57],"this":[58,106],"study,":[59],"we":[60],"investigated":[61],"on":[66],"endothelial":[68],"growth":[69],"factor":[70],"(VEGF)":[71],"production":[72,178],"matrix":[74],"metalloproteinase-2":[75],"(MMP-2)":[76],"activity":[77,164,182],"(two":[78],"important":[79],"angiogenic":[80],"factors)":[81],"human":[83,91,185],"leukemic":[84,92,186],"cell":[85,101,148,187],"lines":[86,102,188],"vitro.":[88],"METHODS:":[89],"Two":[90],"T":[93],"(Molt-4":[94],"Jurkat)":[96],"one":[98],"monocyte":[99],"(U937)":[100],"were":[103,110],"study.":[107],"The":[108,141],"cells":[109,204],"cultured":[111],"complete":[113],"RPMI":[114],"medium":[115],"then":[117],"incubated":[118],"with":[119,153,220],"different":[120],"concentrations":[121],"(0.3-30":[124],"microM)":[125],"presence":[128],"or":[129],"absence":[130],"phorbol":[132],"myristate":[133],"acetate":[134],"(PMA,":[135],"25":[136],"ng/ml)":[137],"48":[139],"hours.":[140],"level":[142],"VEGF":[144,177],"secreted":[145],"culture":[149],"supernatants":[150],"was":[151,168],"measured":[152],"enzyme-linked":[154],"immunosorbent":[155],"assay":[156],"kits":[157],"(R":[158],"D":[160],"systems)":[161],"MMP-2":[163,181],"cell-conditioned":[166],"media":[167],"evaluated":[169],"by":[170],"gelatin":[171],"zymography.":[172],"RESULTS:":[173],"Propranolol":[174,207],"significantly":[175],"decreased":[176],"also":[180],"PMA-activated":[184],"Molt-4,":[189],"Jurkat":[190],"U937":[192],"at":[193],"30":[194],"microM":[195],"concentration":[196],"drug":[199],"compared":[200],"to":[201],"untreated":[202],"control":[203],"(P<0.05).":[205],"CONCLUSION:":[206],"might":[208],"be":[209],"useful":[211],"anti-angiogenic":[212],"agent":[213],"hematopoietic":[215],"malignancies.":[216],"Thus,":[217],"along":[219],"its":[221],"chronic":[222],"long-term":[223],"usage":[224],"cardiac":[226],"problems":[227],"may":[228],"potential":[230],"implication":[231],"leukemia.":[235]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}